Castleark Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Castleark Management's DFTX Position: Q3 2026 in Review
Castleark Management opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 67,160 shares worth $2.56M. The stake represents 0.07% of the portfolio and ranks #196 among its holdings.
354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Castleark Management held 67,160 shares of Definium Therapeutics worth $2.56M as of Q3 2026.
- Definium Therapeutics was a new Castleark Management position in Q3 2026.
- Definium Therapeutics made up 0.07% of Castleark Management's portfolio in Q3 2026, its #196 holding.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.